(S)-Crizotinib

SL-1361

(S)-Crizotinib, >98%

CAS No. : [1374356-45-2]

MDL No. : MFCD22126092

IUPAC Name : 3-[(1S)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-2-pyridinamine

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
250MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
500MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : (S)-Crizotinib is the (S)-enantiomer of Crizotinib, which is a potent inhibitor of c-Met and ALK. Crizotinib is an anti-cancer drug, used for the treatment of non-small cell lung carcinoma (NSCLC). (S)-Crizotinib can also serve as a promising anticancer agent.

References : Huber K. V. M. et al.: Nature, 508, 222, 2014.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.